Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia-Reference-Cited by-同舟云学术

Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia

Published:1991-11 Issue:5 Volume:230 Page:397-405
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:

Author:

OJALA J.-P.,HELVE E.,EHNHOLM C.,AALTO-SETÄLÄ K.,KONTULA K. K.,TIKKANEN M. J.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.1991.tb00464.x/fullpdf

Reference43 articles.

1. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia;Grundy;N Engl J Med,1988

2. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes;Bilheimer;Proc Natl Acad Sci USA,1983

3. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia;Grundy;J Lipid Res,1985

4. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production;Arad;J Lipid Res,1990

5. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia;Illingworth;J Clin Invest,1984

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between Apolipoprotein E Polymorphism and Response to Statins in Group of Hyperlipidemic Patients;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-05-04

2. Cardiovascular Disease Pharmacogenomics;Omics for Personalized Medicine;2013

3. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia;Journal of Clinical Lipidology;2012-11

4. Cardiovascular Pharmacogenetics;Pharmacogenetics and Individualized Therapy;2012-08-08

5. Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy;Lipids in Health and Disease;2012-05-29